Annual Report

The report records Medios Group revenue of 1,357,408 thousand euros for 2021, up 116.7%, with growth driven in part by the Cranach Pharma acquisition. It describes the NewCo Pharma acquisition, completed in January 2022, as strengthening Patient-Specific Therapies and notes mediosconnect's expansion to four German states. Medios also established a Sustainability Committee, published a 2025 sustainability strategy, and set a 2023 climate-neutrality goal for its own sites.